{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:47:23Z","timestamp":1775292443198,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec><jats:title>Background and objectives<\/jats:title><jats:p>Injecting drug use (IDU), a permanent deferral for blood donors, was included in a review of donor selection criteria completed in 2017. Here, we describe what is known about IDU in blood donors in the United Kingdom (UK).<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Data were obtained from routine surveillance of donation testing and confirmed positive donors and a 2013\/2014 UK survey of behaviour and compliance in screen\u2010negative donors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 2009 and 2018, of 22 UK million donations screened, IDU was self\u2010reported at the post\u2010test discussion in 5% (86\/1777) of donors with confirmed positive donations. Recent injecting within 12\u00a0months was reported in 8 HCV\u2010positive donors, but only in 1\/14 donors where it was clear HCV infection had been acquired in the previous 12\u00a0months. Of 65\u00a0439 survey responders, 25 reported IDU, which when weighted to the donor population gave 99\u00b795% compliance. Most of the 111 donors reporting IDU felt it was not important to their donation, mainly because their injecting was in the past, while three HCV\u2010positive recent injectors reported not sharing needles so presumably felt safe to donate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Compliance with the permanent deferral appeared extremely high with low levels of injecting reported by donors, mainly in the past. This agreed with the low\u2010incident HCV infection observed in UK donors. These data contributed to a recommendation to reduce the deferral to 1\u00a0year. Ways of improving compliance in those few donors at current increased risk of infection need to be investigated.<\/jats:p><\/jats:sec>","DOI":"10.1111\/vox.12976","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T20:13:26Z","timestamp":1595535206000},"page":"637-646","source":"Crossref","is-referenced-by-count":4,"title":["What are blood donors telling us about injecting drug use?"],"prefix":"10.1111","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3452-0832","authenticated-orcid":false,"given":"Claire A.","family":"Reynolds","sequence":"first","affiliation":[{"name":"NHS Blood and Transplant\/Public Health England Epidemiology Unit NHS Blood and Transplant London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-892X","authenticated-orcid":false,"given":"Katy L.","family":"Davison","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant\/Public Health England Epidemiology Unit Public Health England London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[{"name":"Statistics, Modelling and Economics Department Public Health England London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2856-0387","authenticated-orcid":false,"given":"Susan R.","family":"Brailsford","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant\/Public Health England Epidemiology Unit NHS Blood and Transplant London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the UK Blood Donor Survey Steering Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"The Blood Safety and Quality Regulations 2005. UK 2005"},{"key":"e_1_2_9_3_1","unstructured":"Directive 2002\/98\/EC of the European Parliament and of the Council 2003"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1994.tb00251.x"},{"key":"e_1_2_9_5_1","unstructured":"Change Notification UK National Blood Services No. 15 \u2010 2015; in JPAC (ed). UK 2015"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000835"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.2009.00969.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13587"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540360035027"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2016.11.005"},{"key":"e_1_2_9_11_1","unstructured":"Public Health England HPS Public Health Wales and Public Health Agency Northern Ireland:Shooting Up: Infections among people who inject drugs in the UK 2015. London 2016"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13063"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800051293"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1994.tb00252.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7142.1413"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2001.00302.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01618.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.2807\/esm.10.02.00518-en"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12144"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02622.x"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13298"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12638"},{"key":"e_1_2_9_23_1","unstructured":"JPAC: The estimated residual risk that a donation made in the infectious window period is not detected on testing: risks specific for HBV HCV and HIV in the UK 2015\u20102017.2018."},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12236"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12554"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13106"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2015-052405"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.058"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12891"},{"key":"e_1_2_9_30_1","unstructured":"Public Health England:Safe Supplies: Monitor Inform Progress. Annual Review from the NHS Blood and Transplant\/Public Health England Epidemiology Unit 2018. London 2019."},{"key":"e_1_2_9_31_1","unstructured":"PolesD; on behalf of theSerious Hazards of Transfusion (SHOT) Steering Group.The 2017 Annual SHOT Report. PHB Bolton\u2010Maggs (ed).2018."},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12225"},{"key":"e_1_2_9_33_1","unstructured":"SaBTO:Advisory Committee on the Safety of Blood Tissues and Organs (SaBTO): Donor Selection Criteria Report (2017); DHSC (ed).2017."}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fvox.12976","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.12976","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vox.12976","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.12976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:45:55Z","timestamp":1693824355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.12976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/vox.12976"],"URL":"https:\/\/doi.org\/10.1111\/vox.12976","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]}}}